GS
Goldman Sachs Group Inc disclosed a 6.7% stake in ATTO
Goldman Sachs Group Inc reported owning 6.7% of Attovia Therapeutics, Inc. (ATTO) (3,041,575 shares) in a Schedule 13G filed Nov 13, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 13, 2026
- Source
- Schedule 13G